Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,166
NCT00557011
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 30, 2004
Completion: Dec 31, 2004
NCT00556296
Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD
Phase: Phase 3
Start: Oct 31, 2004
Completion: Sep 30, 2005
NCT00247572
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
Start: Sep 30, 2005
Completion: Nov 30, 2005
NCT00248092
Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse
Phase: Phase 1/2
Start: Jan 31, 2006
Completion: May 31, 2006
NCT00334880
Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Start: May 31, 2006
Completion: Nov 30, 2006
NCT00337285
An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Start: Jul 31, 2006
Completion: Jun 30, 2008